𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C

✍ Scribed by Marcus Wiedmann; Uwe G. Liebert; Ute Oesen; Heiner Porst; Manfred Wiese; Sabine Schroeder; Ulrich Halm; Joachim Mössner; Frieder Berr

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
98 KB
Volume
31
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of a recombina
Safety and immunogenicity of a recombinant hepatitis B vaccine
✍ E. Dandolos; A. Roumeliotou-Karayannis; S. C. Richardson; Prof. G. Papaevangelou 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.

Immunogenicity of a yeast-recombinant he
Immunogenicity of a yeast-recombinant hepatitis B vaccine in high-risk children
✍ M. G. Rumi; R. Romeo; M. Bortolini; A. Gringeri; A. R. Zanett; P. M. Mannucci; M 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB

Horizontal transmission of hepatitis B virus (HBV) from illicit drug users to their contacts, including young children, can be prevented by active immunization against HBV. Yeast-recombinant hepatitis B vaccines are now available for this purpose, but their potential efficacy in such high-risk conta

Immunogenicity of a five-microgram dose
Immunogenicity of a five-microgram dose of hepatitis B vaccine
✍ George Papaevangelou; Anastasia Roumeliotou-Karayannis; Charalambos Vissoulis; S 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB

The immunogenicity of a 5-micrograms dose of vaccine (H-B-Vax, MSD) was evaluated in 50 young adults (17-19 years). Results were compared to our previous studies using similarly prepared vaccines using 20 micrograms and 10 micrograms per dose with the same trial protocol in a comparable population.

Decreased nitric oxide production in chr
Decreased nitric oxide production in chronic viral hepatitis B and C
✍ Amaro, María José; Bartolomé, Javier; Pardo, Margarita; Cotonat, Teresa; López-F 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 1 views

Nitric oxide is a free radical gas molecule which may be implicated in antiviral defense. However, there is no information about its possible role in chronic viral hepatitis B and C. In this study we have analyzed the serum levels of NO 2 -(as an index of nitric oxide generation) from patients with